Computational Biology, Quantitative Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
Antimicrob Agents Chemother. 2011 Sep;55(9):4267-76. doi: 10.1128/AAC.00052-11. Epub 2011 Jul 11.
There is a global emergence of multidrug-resistant (MDR) strains of Klebsiella pneumoniae, a Gram-negative enteric bacterium that causes nosocomial and urinary tract infections. While the epidemiology of K. pneumoniae strains and occurrences of specific antibiotic resistance genes, such as plasmid-borne extended-spectrum β-lactamases (ESBLs), have been extensively studied, only four complete genomes of K. pneumoniae are available. To better understand the multidrug resistance factors in K. pneumoniae, we determined by pyrosequencing the nearly complete genome DNA sequences of two strains with disparate antibiotic resistance profiles, broadly drug-susceptible strain JH1 and strain 1162281, which is resistant to multiple clinically used antibiotics, including extended-spectrum β-lactams, fluoroquinolones, aminoglycosides, trimethoprim, and sulfamethoxazoles. Comparative genomic analysis of JH1, 1162281, and other published K. pneumoniae genomes revealed a core set of 3,631 conserved orthologous proteins, which were used for reconstruction of whole-genome phylogenetic trees. The close evolutionary relationship between JH1 and 1162281 relative to other K. pneumoniae strains suggests that a large component of the genetic and phenotypic diversity of clinical isolates is due to horizontal gene transfer. Using curated lists of over 400 antibiotic resistance genes, we identified all of the elements that differentiated the antibiotic profile of MDR strain 1162281 from that of susceptible strain JH1, such as the presence of additional efflux pumps, ESBLs, and multiple mechanisms of fluoroquinolone resistance. Our study adds new and significant DNA sequence data on K. pneumoniae strains and demonstrates the value of whole-genome sequencing in characterizing multidrug resistance in clinical isolates.
目前,革兰氏阴性肠杆菌科细菌肺炎克雷伯菌出现了全球范围的多药耐药(MDR)菌株。这种细菌会导致医院获得性和尿路感染。虽然已经广泛研究了肺炎克雷伯菌菌株的流行病学和特定抗生素耐药基因(如质粒携带的扩展谱β-内酰胺酶(ESBLs))的发生情况,但仅有 4 株完整的肺炎克雷伯菌基因组可供使用。为了更好地了解肺炎克雷伯菌的多药耐药因素,我们通过焦磷酸测序确定了两种具有不同抗生素耐药谱的菌株的近完整基因组 DNA 序列,这两种菌株分别是对多种临床使用的抗生素(包括扩展谱β-内酰胺类、氟喹诺酮类、氨基糖苷类、甲氧苄啶和磺胺甲恶唑)具有广泛耐药性的 1162281 菌株和对多种抗生素敏感的 JH1 菌株。对 JH1、1162281 菌株和其他已发表的肺炎克雷伯菌基因组的比较基因组分析揭示了一组由 3631 个保守直系同源蛋白组成的核心基因集,这些蛋白被用于构建全基因组系统发育树。JH1 和 1162281 菌株与其他肺炎克雷伯菌菌株之间的密切进化关系表明,临床分离株的遗传和表型多样性的很大一部分是由于水平基因转移。使用经过精心筛选的 400 多个抗生素耐药基因列表,我们确定了区分 MDR 菌株 1162281 和敏感菌株 JH1 的抗生素谱的所有因素,例如存在额外的外排泵、ESBLs 和多种氟喹诺酮类耐药机制。我们的研究增加了关于肺炎克雷伯菌菌株的新的和重要的 DNA 序列数据,并展示了全基因组测序在表征临床分离株的多药耐药性方面的价值。